The US FDA has issued ‘Good Day Letters’ to dsm-firmenich for three Generally Recognized as Safe (GRAS) notices submitted for the human milk oligosaccharides (HMOs) LNFP-l/2’-FL and hypoallergenic grade LNnT and 2’-FL.
Human milk oligosaccharides (HMOs) — important groups of carbohydrates in human breast milk — can, in some cases, be secreted in very high concentrations, and still be safe and well-tolerated by infants.
On this week’s podcast, we have three conversations: with Ian Smith, sales director at PFF; Dr Ardythe Morrow, Professor of Epidemiology and Pediatrics at the University of Cincinnati College of Medicine and Cincinnati Children's Hospital Medical...
Adventa Bioscience, a company dedicated to improving adult human health, has announced the launch of Trulacta, the world's first and only supplement made entirely of human milk.
Belgian biotech company Inbiose, which develops human milk oligosaccharides (HMOs), has submitted its application for a Generally Recognized as Safe (GRAS) approval by the US Food & Drug Administration (FDA) of four HMOs.
Cow and goat-based infant formulas were found to impact the gut microbial activity and exert beneficial bifidogenic effects similar to human milk, despite the absence of oligosaccharides.
Abbott has launched Similac Pro-Advance with a 2'-Fucosyllactose Oligosaccharide (2'-FL) not derived from breast milk, making it the first product in Canada with the ingredient in infant formula.
Kyowa Hakko Bio Ltd, a subsidiary of Kirin Holdings Company, Limited, has announced it will establish a new facility to manufacture human milk oligosaccharides (HMOs) in Thailand.
Chr. Hansen Holding A/S has entered into an agreement to acquire all of the shares of Jennewein Biotechnologie GmbH, a leading player in the Human Milk Oligosaccharides (HMO) market.
On the Dairy Dialog podcast we have two interviews this week, with Conagen VP of innovation, Dr Casey Lippmeier, and we also talk to Joan Bombardo, managing director of Ornua Ingredients Europe. We also have our weekly look at the global dairy markets,...
US biotechnology company Conagen has established a novel and proprietary process for the scalable production of a non-GMO human milk oligosaccharide (HMO), an important nutritional compound only found in human milk.
Researchers at the National Institute of Standards and Technology (NIST) in the US have recently doubled the size of a reference library that includes examples of a certain type of carbohydrate found in milk from humans and several other animals.
DuPont Nutrition & Biosciences recently released the findings of a study showing the effects Care4U 2’-FL had on dental caries-associated bacterium Streptococcus mutans.
German biotechnology company Jennewein Biotechnologie GmbH has published the latest results from its norovirus research program in the Journal of Biotechnology.
Royal DSM, a global science-based company in nutrition, health and sustainable living, has completed its acquisition of Danish-headquartered Glycom A/S, the world's leading supplier of Human Milk Oligosaccharides (HMO) for an enterprise value of...
Global nutrition name, Royal DSM, reaches agreement to purchase Human Milk Oligosaccharides (HMO) supplier, Glycom, to progress the prebiotic for infants.
Jennewein Biotechnologie has filed a patent infringement suit against Nestlé concerning the unauthorised use of a human milk oligosaccharide (HMO) purification method for infant formula.
Jennewein Biotechnologie GmbH, a German company involved in the research and manufacture of human milk oligosaccharides (HMO), and Inner Mongolia Yili Industrial Group (Yili Group), China’s leading dairy company, have signed a Memorandum of Understanding...
Human milk oligosaccharides (HMOs) have extensive potential to offer a range of health benefits in products beyond infant formula, DuPont's global business director for HMOs, Steen Lyck, said at Vitafoods Asia on Tuesday.
